Fig. 3From: Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cellsThe expression of BCR/ABL protein in CML cells was decreased after Ab@Tf-Cou6-PLGA NPs treatment. a The expression of BCR/ABL and p-BCR/ABL in CML cells after Ab@Tf-Cou6-PLGA NPs treatment was detected by western blot assay. b The expression of p-STAT5, p-ERK and p-CRKL in CML cells was detected by western blot assayBack to article page